Drug recall · August 2, 2023
FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL Bag recall
Why: cGMP deviations: due to shipment of rejected units.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL Bag, Injection for Epidural Use (fentaNYL Concentration - 2 mcg/mL), Rx Only, Single Dose Container, SCA Pharmaceuticals, 755 Rainbow Rd, Windsor, CT 06095, NDC# 70004-0253-40
- Lots / codes
Lot # 1223047134, Use By: 09/21/2023
- Quantity
- 183 bags
- Company
- SCA Pharmaceuticals, Windsor, CT
- Distribution
- KY and NJ
- Initiated
- July 20, 2023 · Voluntary: Firm initiated
- Classified
- July 26, 2023
- Reported
- August 2, 2023
- Ended
- September 21, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupivacaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.